Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

about

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

Item

http://www.wikidata.org/entity/Q57301014

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@en

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@nl

type

Item

label

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@en

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@nl

prefLabel

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@en

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@nl

P1476

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

@en

P2093

Chan Su Park

http://www.w3.org/2001/XMLSchema#string

Hyun-Ah Kim

http://www.w3.org/2001/XMLSchema#string

In-Chul Park

http://www.w3.org/2001/XMLSchema#string

Jae-Sung Kim

http://www.w3.org/2001/XMLSchema#string

Jihye Choi

http://www.w3.org/2001/XMLSchema#string

Jin Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Min-Ki Seong

http://www.w3.org/2001/XMLSchema#string

Sung-Eun Hong

http://www.w3.org/2001/XMLSchema#string

Woo Chul Noh

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications

Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age

Premature menopause or early menopause: long-term health consequences

A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors

American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.

Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progre

P304

949-956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EC-18-0180

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30300533

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6144937

http://www.w3.org/2001/XMLSchema#string